CGS

Cogstate Limited

1 day chart

About CGS

Cogstate Ltd (CGS) is involved in creation, validation and commercialisation of digital brain health assessments and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Cogstate solutions are widely used in both academic and industry sponsored research. Cogstate technology had been deployed in more than: 1,800 academic research studies and 400 industry sponsored clinical trials.

Buy Australian shares starting with CGS. Invest today with a CHESS-sponsored investing platform!

Sector

Health Care

CEO

Industry

Health Care Technology

Website

cogstate.com

Market Capitalisation

$247M

Price-earnings ratio

46.89

Dividend yield

NaN%

High today

$1.42

Low today

$1.35

Open price

$1.40

52-week high

$2.46

52-week low

$1.14

Announcements

CGS FAQs

Can I buy CGS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CGS shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Cogstate Limited?

One share of Cogstate Limited is valued at $1.40.

What is the ticker symbol for Cogstate Limited?

The ticker symbol for Cogstate Limited is CGS.

How do I buy CGS shares in Australia?

To buy CGS stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in CGS

What is the 52-week high for Cogstate Limited stock?

The Cogstate Limited 52-week high stock price is $2.46.

What is the 52-week low for Cogstate Limited stock?

The Cogstate Limited 52-week low stock price is $1.14.

What is the market capitalisation of Cogstate Limited CGS?

As of 05/12/2023 Cogstate Limited has a market cap of $247M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.